KeyBanc raised the firm’s price target on CareTrust REIT (CTRE) to $40 from $36 and keeps an Overweight rating on the shares. The firm continues to favor Healthcare REITs with exposure to above-average growth in senior housing operating fundamentals, and investment pipelines that support accretive external growth. While KeyBanc is incrementally constructive on companies with growing Senior Housing Operating Portfolio exposure, earnings accretion, available dry powder and operating execution may be key to gain investor confidence. The firm also expects skilled nursing fundamentals to remain attractive in 2026 but continues to monitor the reimbursement backdrop following the elimination of enhanced FMAP funding, but view rent coverage levels to be relatively healthy.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTRE:
- CareTrust REIT price target raised to $41 from $38 at Wells Fargo
- CareTrust REIT (CTRE) Buy Rating: Strategic Growth and Strong Financial Health Drive Positive Outlook
- CareTrust REIT initiated with a Buy at UBS
- CareTrust REIT price target raised to $41 from $38 at BofA
- CareTrust REIT price target raised to $41 from $36 at RBC Capital